WFA
WestHill Financial Advisors’s Nurix Therapeutics NRIX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.6M | Hold |
228,333
| – | – | 0.55% | 19 |
|
2025
Q1 | $2.71M | Hold |
228,333
| – | – | 0.62% | 18 |
|
2024
Q4 | $4.3M | Sell |
228,333
-10,000
| -4% | -$188K | 0.96% | 16 |
|
2024
Q3 | $5.36M | Sell |
238,333
-45,000
| -16% | -$1.01M | 1.2% | 16 |
|
2024
Q2 | $5.91M | Hold |
283,333
| – | – | 1.43% | 15 |
|
2024
Q1 | $4.16M | Hold |
283,333
| – | – | 1.02% | 16 |
|
2023
Q4 | $2.92M | Hold |
283,333
| – | – | 0.78% | 17 |
|
2023
Q3 | $2.23M | Hold |
283,333
| – | – | 0.65% | 18 |
|
2023
Q2 | $2.83M | Hold |
283,333
| – | – | 0.8% | 17 |
|
2023
Q1 | $2.52M | Hold |
283,333
| – | – | 0.75% | 17 |
|
2022
Q4 | $3.11M | Hold |
283,333
| – | – | 0.99% | 16 |
|
2022
Q3 | $3.69M | Hold |
283,333
| – | – | 1.26% | 16 |
|
2022
Q2 | $3.59M | Hold |
283,333
| – | – | 1.19% | 16 |
|
2022
Q1 | $3.97M | Hold |
283,333
| – | – | 1.14% | 16 |
|
2021
Q4 | $8.2M | Hold |
283,333
| – | – | 2.32% | 11 |
|
2021
Q3 | $8.49M | Buy |
+283,333
| New | +$8.49M | 2.62% | 10 |
|
2021
Q1 | $8.81M | Buy |
+283,333
| New | +$8.81M | 3.13% | 9 |
|